ANN ARBOR, Mich., Sept. 3, 2025 /PRNewswire/ — Two leaders in lipid nanoparticle (LNP) development have partnered to make PEG-free shielding lipids available to researchers advancing LNPs for non-viral drug delivery, gene therapy, mRNA vaccines, and biologic therapies. Cayman Chemical, a…
